Sinnaeve Peter R, Zeymer Uwe, Bueno Héctor, Danchin Nicolas, Medina Jesús, Sánchez-Covisa Joaquín, Licour Muriel, Annemans Lieven, Jukema J Wouter, Pocock Stuart, Storey Robert F, Van de Werf Frans
University Hospitals Leuven, Belgium
Institut für Herzinfarktforschung Ludwigshafen, Germany.
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):254-62. doi: 10.1177/2048872614551544. Epub 2014 Sep 10.
The EPICOR observational study was designed to describe antithrombotic strategies in a broad acute coronary syndrome (ACS) population; it also included information on inter-hospital transfers and institutional resources.
EPICOR enrolled 10,568 consecutively discharged patients with ST-elevation (STE) or non-STE (NSTE) ACS in 555 centres in 20 countries across Europe and Latin America. Patients were categorized as non-transferred, transferred in from another hospital and then discharged, or transferred out to a second hospital but discharged from their initial hospital after transfer back. Two-thirds of ACS patients were non-transferred, of which only 14% were hospitalized at a centre without a catheterization laboratory, and one-third were transferred in or transferred out. Almost all transferred out patients were transferred out to a hospital with catheterization facilities, most often for primary/urgent/rescue (78%) or planned catheterization (18%) in STE myocardial infarction (STEMI), and primary/urgent/rescue (44%) or planned (43%) catheterization in NSTE-ACS. Transferred in patients were more likely to have a STEMI (60%) than non-transferred (44%) and transferred out patients (36%). In STEMI patients, time from symptom onset to catheterization was shorter in non-transferred patients (median 3.5 h vs. 5.9 h for transferred in and 6.3 h for transferred out). In NSTE-ACS, cardiac markers were positive in 66% of non-transferred patients versus 78% and 82% in transferred in and transferred out, respectively.
The lack of on-site 24/7 facilities or the availability of more advanced care are frequent reasons for inter-hospital transfer in ACS. Further follow-up of these patients will help to determine whether these practice patterns affect outcome.
EPICOR观察性研究旨在描述广泛的急性冠状动脉综合征(ACS)人群中的抗血栓治疗策略;该研究还纳入了关于院间转运和机构资源的信息。
EPICOR在欧洲和拉丁美洲20个国家的555个中心连续纳入了10568例ST段抬高型(STE)或非ST段抬高型(NSTE)ACS出院患者。患者被分为未转运、从另一家医院转入后出院,或转出至第二家医院但转回初始医院后出院。三分之二的ACS患者未转运,其中只有14%在没有导管实验室的中心住院,三分之一的患者被转入或转出。几乎所有转出患者都被转至有导管设施的医院,在ST段抬高型心肌梗死(STEMI)中,最常见的是进行初级/紧急/抢救性(78%)或计划性导管插入术(18%),在NSTE-ACS中,是初级/紧急/抢救性(44%)或计划性(43%)导管插入术。转入患者比未转运患者(44%)和转出患者(36%)更易发生STEMI(60%)。在STEMI患者中,未转运患者从症状发作到进行导管插入术的时间较短(中位数为3.5小时,转入患者为5.9小时,转出患者为6.3小时)。在NSTE-ACS中,66%的未转运患者心脏标志物呈阳性,而转入和转出患者分别为78%和82%。
缺乏全天候现场设施或更高级护理服务的可及性是ACS患者院间转运的常见原因。对这些患者的进一步随访将有助于确定这些治疗模式是否会影响预后。